|
CMTM6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.475800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.255750E-01 |
| Normal-vs-Stage2 |
1.216050E-01 |
| Normal-vs-Stage3 |
3.471600E-01 |
| Normal-vs-Stage4 |
8.596200E-01 |
| Stage1-vs-Stage2 |
4.774800E-01 |
| Stage1-vs-Stage3 |
9.519000E-01 |
| Stage1-vs-Stage4 |
6.167000E-01 |
| Stage2-vs-Stage3 |
6.255600E-01 |
| Stage2-vs-Stage4 |
3.953400E-01 |
| Stage3-vs-Stage4 |
6.747400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.246620E-01 |
| Normal-vs-AfricanAmerican |
3.275800E-02 |
| Normal-vs-Asian |
5.350000E-01 |
| Caucasian-vs-AfricanAmerican |
2.957800E-01 |
| Caucasian-vs-Asian |
9.304800E-01 |
| AfricanAmerican-vs-Asian |
6.339600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.486830E-01 |
| Normal-vs-Female |
3.984700E-03 |
| Male-vs-Female |
2.914200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.775200E-01 |
| Normal-vs-Extreme_Weight |
5.225200E-01 |
| Normal-vs-Obese |
5.974200E-02 |
| Normal-vs-Extreme_Obese |
5.414000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.832600E-01 |
| Normal_Weight-vs-Obese |
1.429010E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.239200E-01 |
| Extreme_Weight-vs-Obese |
1.548790E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.407400E-01 |
| Obese-vs-Extreme_Obese |
6.127400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.801600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.515400E-03 |
| Normal-vs-Age(61-80Yrs) |
3.411000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.268000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.881400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.429600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.969500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.604500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.043050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.528200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.390400E-02 |
| Normal-VS-Type2 PRCC |
4.661000E-01 |
| Normal-VS-KIRP CIMP |
3.239900E-03 |
| Normal-VS-Unclassified PRCC |
7.043500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.599900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.028800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.999400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.864740E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.182900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.942200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.290400E-01 |
| Normal-vs-N1 |
1.607210E-01 |
| Normal-vs-N2 |
4.704400E-01 |
| N0-vs-N1 |
1.136040E-01 |
| N0-vs-N2 |
4.356400E-01 |
| N1-vs-N2 |
7.386200E-01 |
|
|
